From FDA approvals streamlining access to critical therapies to new breakthroughs in challenging malignancies, the field of cancer care continues to demonstrate remarkable progress.

Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants.

Opinion: Orrick's Irena Royzman and Dana Sublett write that judges have done a good job in multiple decisions that protect ...

Onward Medical announced today that it submitted its ARC-EX system for expanded FDA indication and for CE mark approval.

The FDA has accepted Aquestive Therapeutics’ new drug application for its Anaphylm sublingual epinephrine film for treating ...